The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on a Type II Variation regulatory application and recommended the approval of a pre-filled syringe presentation of Takhzyro (lanadelumab) from Takeda Pharmaceutical Company Limited.  Takhzyro is a subcutaneous injectable prescription medication approved in Europe for routine prevention of … Continue reading Positive CHMP Opinion for Pre-filled Syringe Presentation of Takhzyro